The adverse effect of treatment prolongation in cervical carcinoma.
about
Neoadjuvant chemotherapy for locally advanced cervix cancerWhich clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trials.Brachytherapy in the treatment of cervical cancer: a review.Repopulation of tumor cells during fractionated radiotherapy and detection methods (Review).Radical radiotherapy for locally advanced cancer of uterine cervixBiological aspects of conformal therapy.Analysis of factors contributing to the low survival of cervical cancer patients undergoing radiotherapy in KenyaPatient navigation for American Indians undergoing cancer treatment: utilization and impact on care delivery in a regional healthcare center.Current situation of high-dose-rate brachytherapy for cervical cancer in Brazil.Addressing Cancer Disparities Among American Indians through Innovative Technologies and Patient Navigation: The Walking Forward ExperienceTherapeutic Mechanisms of Treatment in Cervical and Vaginal Cancer.[Prognostic factors of disease-free survival in patients with uterine cervix tumor].21 years of biologically effective doseAmerican Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy.Quality Research in Radiation Oncology analysis of clinical performance measures in the management of gastric cancer.Pure accelerated radiation versus concomitant chemoradiation in selected cases of locally advanced carcinoma cervix: a prospective studyMetrics for evaluating patient navigation during cancer diagnosis and treatment: crafting a policy-relevant research agenda for patient navigation in cancer careRadiation Duration in Women with Cervical Cancer Treated with Primary Chemoradiation: A Population-Based AnalysisFactors Predictive of Protracted Course of Radiation Therapy in Patients Treated with Definitive Chemoradiation for Cervical CancerEstablishing a patient navigator program to reduce cancer disparities in the American Indian communities of Western South Dakota: initial observations and results.Waiting time for radiation therapy in breast cancer patients in Quebec from 1992 to 1998: a study of surgically treated breast cancer patients in Quebec documents and helps to explain increased waiting times for radiation therapyA preliminary results of a randomized trial comparing monthly 5-flourouracil and cisplatin to weekly cisplatin alone combined with concurrent radiotherapy for locally advanced cervical cancer.Concurrent chemoradiation versus radiotherapy alone for the treatment of locally advanced cervical cancer in a low-resource setting.Personalized medicine: challenge and promise.Management pathway for patients with cervical cancer in the Auckland region 2003-2007.The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy.Patterns of care study of brachytherapy in New South Wales: cervical cancer treatment quality depends on caseload.Impact of treatment time-related factors on prognoses and radiation proctitis after definitive chemoradiotherapy for cervical cancer.Comparison Between Concurrent EBRT and ICA with Conventional EBRT Followed by ICA in Cervical Cancer.CyberKnife Boost for Patients with Cervical Cancer Unable to Undergo Brachytherapy.Pulsed brachytherapy: a modelled consideration of repair parameter uncertainties and their influence on treatment duration extension and daytime-only "block-schemes".Brachytherapy for cancer of the cervix: an Australian and New Zealand survey of current treatment techniques.Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone.Five-year outcome of concurrent radiotherapy and chemotherapy in Saudi women with locally advanced cervical cancer: single-institution experience.The prognostic impact of overall treatment time on disease outcome in uterine cervical cancer patients treated primarily with concomitant chemoradiotherapy: a nationwide Taiwanese cohort study.Barriers to Timely Completion of Radiation Therapy in Patients with Cervical Cancer in an Urban Tertiary Care Center.Compliance to the prescribed overall treatment time (OTT) of curative radiotherapy in normal clinical practice and impact on treatment duration of counteracting short interruptions by treating patients on Saturdays.Simultaneous integrated boost (SIB) of the parametrium and cervix in radiotherapy for uterine cervical carcinoma: a dosimetric study using a new alternative approach.The response of tumours with Gompertzian growth characteristics to fractionated radiotherapy.Feasibility of split-course stereotactic ablative radiotherapy for oligometastases.
P2860
Q24247192-62B3AC58-8FA8-4E6C-B9F2-E027D3422C89Q30442543-B2C7B098-41D4-4BC8-93D6-A8DAE5F324BCQ33709835-62F62AC0-DC5C-4721-BABA-0BD4D9F722C3Q33727528-AA888587-3E8E-4F8B-B98C-7C02EE530130Q33746857-8AC2DE29-310D-4DAB-8564-FCFD12A94300Q34091010-4DFC74F1-AD09-4ABE-9743-40897065D14DQ35036419-5EBF9C71-2E0A-473C-8629-B764113C5084Q35038180-9E119809-08CD-4DA5-9425-E26076783AF2Q35109786-41AD285E-8F86-433A-825D-6D0480E703AEQ35971405-A062BE25-E776-4AD4-A91B-E8075CFD94ADQ36195902-9739DDE8-6DCB-4DCB-BB20-CF6BAE788877Q36250262-5966A078-0F4F-480E-9AA0-8EE1916D64F2Q36324701-BA462E5B-D62F-47DD-9CEB-625E5B804BDCQ36372117-D43B7761-AF24-4D23-942B-72AFB1FEFBA3Q36532854-97BDAD99-95E3-4646-BE1E-5A56DFC0FE06Q36620134-BB816509-F460-4027-BD80-F00B84683057Q36757303-00E1A5BA-0402-407B-9BAC-E521036642F4Q36807766-FBB510D8-3D88-41EF-A941-4E880DA504F8Q36874439-01CAE9E2-1A73-403C-98A6-F0B7049EA1C0Q36914759-2C438554-926E-4F2F-8031-4CD9520F1FFAQ36978331-CD4A5DA9-2AEC-4DD5-892D-2F4861FE1E56Q37447050-310DB0E0-800E-41BB-90EC-7AFF6DB0B2C7Q37580497-884607C7-11D0-4105-8233-1E6A2D103671Q37612553-5F801A09-D2FF-463F-9BDA-7A6BD53F1319Q37893227-42E68EA8-AEAB-424C-8D6E-334374AC4B0FQ38027098-B84A44F8-AE75-45E6-AC66-BA6F7BC2F97FQ39029959-A88FE7A3-90CF-452B-8734-FF3327D4CF06Q41368193-34FC77E6-CBB3-4008-B505-6F07E1C61AF8Q41991098-9797EB4E-357A-4908-BD2F-E88E2C3502A2Q42175097-889D9E80-2B18-44ED-99A0-2201DC2F99D0Q42419888-853A43FC-EF85-4850-878E-CBD226D6C481Q43688045-4256CEFC-4177-4A4E-9B28-7A406F6B8102Q45151605-75221C3B-69C1-4DB0-BCDD-373FD2D1DD72Q45800131-1A761D47-254E-4353-BC2B-4677CA0D538CQ45809509-7487C3B2-7E31-4B56-93D4-712963E5AEA5Q46617324-D2182C36-48E1-42BD-BA5E-17D051573D6BQ46818658-75EE3989-F3E3-4E93-811E-F28F8AA18BE8Q50179081-D70F3463-9090-46C4-B6C9-DB13C1EB017AQ52256436-2CC4CA62-2FB2-426A-AB77-AC9E9D22DECFQ55103310-03482F56-F2DA-49F6-896E-46B46E897B8B
P2860
The adverse effect of treatment prolongation in cervical carcinoma.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
The adverse effect of treatment prolongation in cervical carcinoma.
@en
The adverse effect of treatment prolongation in cervical carcinoma.
@nl
type
label
The adverse effect of treatment prolongation in cervical carcinoma.
@en
The adverse effect of treatment prolongation in cervical carcinoma.
@nl
prefLabel
The adverse effect of treatment prolongation in cervical carcinoma.
@en
The adverse effect of treatment prolongation in cervical carcinoma.
@nl
P2093
P1476
The adverse effect of treatment prolongation in cervical carcinoma.
@en
P2093
Buchler DA
Chappell R
Hartmann TJ
Kinsella TJ
Petereit DG
Sarkaria JN
Thomadsen BR
P304
P356
10.1016/0360-3016(94)00635-X
P407
P577
1995-07-01T00:00:00Z